Brief: Five New Drug Candidates Show Promise As Ainos Pursues Licensing Partners Of Its Low-Dose Oral Interferon Formulation
03/11/2022 11:18
Nov 3 (Reuters) - Ainos Inc AIMD.O :
* FIVE NEW DRUG CANDIDATES SHOW PROMISE AS AINOS PURSUES
LICENSING
PARTNERS OF ITS LOW-DOSE ORAL INTERFERON FORMULATION
Source text for Eikon: ID:nPn3c8ZcDa
Further company coverage: AIMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ainos
See all newsAinos Q1 loss narrows as costs fall
Brief: Ainos On Dec 30 2025, Enters Distribution Agreement With Trusval Technology
Brief: Ainos Inc Receives IRB Approval From National Taiwan University Hospital For Hiv-Oral Warts Clinical Trial
Brief: Ainos Announces Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome
Brief: Ainos Secures Taiwan Invention Patent And Advances Global Patent Protection For Veldona